Compare
UnitedHealth Group Inc vs Cigna Group vs Elevance Health, Inc. vs Centene Corp
| Latest fiscal year | UnitedHealth Group Inc UNH | Cigna Group CI | Elevance Health, Inc. ELV | Centene Corp CNC |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $447.57B | $274.90B | $199.12B | $194.78B |
| Revenue growth (YoY) | +11.8% | +11.2% | +12.5% | +19.4% |
| Gross margin | n/a | n/a | n/a | 7.3% |
| Operating margin | 4.2% | 3.3% | 3.6% | -3.9% |
| Net margin | 2.7% | 2.3% | 2.8% | -3.4% |
| Net income | $12.06B | $6.29B | $5.66B | -$6.67B |
| EPS (Diluted) | $13.23 | $22.18 | $25.21 | -$13.53 |
| Operating cash flow | $19.70B | $9.60B | $4.29B | $5.09B |
| Free cash flow | $16.07B | n/a | $3.17B | $4.32B |
| Cash & equivalents | $24.36B | $7.68B | $9.49B | $17.89B |
| Total assets | $309.58B | $157.92B | $121.49B | $76.75B |
| Total liabilities | $207.88B | $116.05B | $77.47B | $56.69B |
| Shareholders' equity | $100.09B | $41.87B | $43.88B | $20.03B |
| Return on year-end equity | 12.0% | 15.0% | 12.9% | -33.3% |
| Shares outstanding | 906.00M | 263.46M | 220.72M | 491.76M |
Revenue, most recent five fiscal years
| Fiscal year | UnitedHealth Group Inc | Cigna Group | Elevance Health, Inc. | Centene Corp |
|---|---|---|---|---|
| Latest | $447.57B Ended 2025-12-31 | $274.90B Ended 2025-12-31 | $199.12B Ended 2025-12-31 | $194.78B Ended 2025-12-31 |
| 1 year earlier | $400.28B Ended 2024-12-31 | $247.12B Ended 2024-12-31 | $177.01B Ended 2024-12-31 | $163.07B Ended 2024-12-31 |
| 2 years earlier | $371.62B Ended 2023-12-31 | $195.26B Ended 2023-12-31 | $171.34B Ended 2023-12-31 | $154.00B Ended 2023-12-31 |
| 3 years earlier | $324.16B Ended 2022-12-31 | $180.52B Ended 2022-12-31 | $156.59B Ended 2022-12-31 | $144.55B Ended 2022-12-31 |
| 4 years earlier | $287.60B Ended 2021-12-31 | $174.07B Ended 2021-12-31 | $138.64B Ended 2021-12-31 | $125.98B Ended 2021-12-31 |